Localization of thrombospondin-1 and myofibroblasts during corneal wound repair

Experimental Eye Research

Volumn 93, Issue 4, 2011, Pages 534-540

  Matsuba, Mariko ^a   Hutcheon, Audrey E K ^a   Zieske, James D ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Corneal stroma; Corneal wound repair; Keratectomy; Myofibroblasts; Provisional matrix; Thrombospondin 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; KI 67 ANTIGEN; THROMBOSPONDIN 1;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTERY ENDOTHELIUM; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA INJURY; DEBRIDEMENT; ENDOTHELIUM; EPITHELIUM; IMMUNOFLUORESCENCE; KERATECTOMY; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; STROMA; WOUND HEALING;

ACTINS; ANIMALS; BASEMENT MEMBRANE; BIOLOGICAL MARKERS; CELL TRANSDIFFERENTIATION; CORNEA; CORNEAL KERATOCYTES; DEBRIDEMENT; DISEASE MODELS, ANIMAL; EYE INJURIES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; KI-67 ANTIGEN; MICROSCOPY, FLUORESCENCE; MYOFIBROBLASTS; RATS; RATS, SPRAGUE-DAWLEY; THROMBOSPONDIN 1; WOUND HEALING;

EID: 80055056452     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2011.06.018     Document Type: Article

References (55)

1. Agah A., Kyriakides T.R., Lawler J., Bornstein P. The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice. Am. J. Pathol. 2002, 161:831-839.
2. Baenziger N.L., Brodie G.N., Majerus P.W. A thrombin-sensitive protein of human platelet membranes. Proc. Natl. Acad. Sci. U S A 1971, 68:240-243.
3. Berryhill B.L., Kane B., Stramer B.M., Fini M.E., Hassell J.R. Increased SPARC accumulation during corneal repair. Exp. Eye Res. 2003, 77:85-92.
4. Bornstein P., Agah A., Kyriakides T.R. The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury. Int. J. Biochem. Cell Biol. 2004, 36:1115-1125.
5. Bornstein P. Thrombospondins as matricellular modulators of cell function. J. Clin. Invest. 2001, 107:929-934.
6. Cao Z., Wu H.K., Bruce A., Wollenberg K., Panjwani N. Detection of differentially expressed genes in healing mouse corneas, using cDNA microarrays. Invest. Ophthalmol. Vis. Sci. 2002, 43:2897-2904.
7. Carlson C.B., Lawler J., Mosher D.F. Structures of thrombospondins. Cell Mol. Life Sci. 2008, 65:672-686.
8. Chatila K., Ren G., Xia Y., Huebener P., Bujak M., Frangogiannis N.G. The role of the thrombospondins in healing myocardial infarcts. Cardiovasc. Hematol. Agents Med. Chem. 2007, 5:21-27.
9. Chen H., Herndon M.E., Lawler J. The cell biology of thrombospondin-1. Matrix Biol. 2000, 19:597-614.
10. Crawford S.E., Stellmach V., Murphy-Ullrich J.E., Ribeiro S.M., Lawler J., Hynes R.O., Boivin G.P., Bouck N. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 1998, 93:1159-1170.
11. Darby I., Skalli O., Gabbiani G. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab. Invest. 1990, 63:21-29.
12. Desmouliere A., Geinoz A., Gabbiani F., Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 1993, 122:103-111.
13. Frangogiannis N.G., Ren G., Dewald O., Zymek P., Haudek S., Koerting A., Winkelmann K., Michael L.H., Lawler J., Entman M.L. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation 2005, 111:2935-2942.
14. Friedman S.L. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N. Engl. J. Med. 1993, 328:1828-1835.
15. Fujikawa L.S., Foster C.S., Harrist T.J., Lanigan J.M., Colvin R.B. Fibronectin in healing rabbit corneal wounds. Lab. Invest. 1981, 45:120-129.
16. Hiscott P., Seitz B., Schlotzer-Schrehardt U., Naumann G.O. Immunolocalisation of thrombospondin 1 in human, bovine and rabbit cornea. Cell Tissue Res. 1997, 289:307-310.
17. Hiscott P., Armstrong D., Batterbury M., Kaye S. Repair in avascular tissues: fibrosis in the transparent structures of the eye and thrombospondin 1. Histol. Histopathol. 1999, 14:1309-1320.
18. Hugo C., Shankland S.J., Pichler R.H., Couser W.G., Johnson R.J. Thrombospondin 1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the rat. Kidney Int. 1998, 53:302-311.
19. Huh M.I., Chang Y., Jung J.C. Temporal and spatial distribution of TGF-beta isoforms and signaling intermediates in corneal regenerative wound repair. Histol. Histopathol. 2009, 24:1405-1416.
20. Huh M.I., Kim Y.H., Park J.H., Bae S.W., Kim M.H., Chang Y., Kim S.J., Lee S.R., Lee Y.S., Jin E.J., Sonn J.K., Kang S.S., Jung J.C. Distribution of TGF-beta isoforms and signaling intermediates in corneal fibrotic wound repair. J. Cell Biochem. 2009, 108:476-488.
21. Hutcheon A.E., Guo X.Q., Stepp M.A., Simon K.J., Weinreb P.H., Violette S.M., Zieske J.D. Effect of wound type on Smad 2 and 4 translocation. Invest. Ophthalmol. Vis. Sci. 2005, 46:2362-2368.
22. Jester J.V., Rodrigues M.M., Herman I.M. Characterization of avascular corneal wound healing fibroblasts. New insights into the myofibroblast. Am. J. Pathol. 1987, 127:140-148.
23. Jester J.V., Petroll W.M., Barry P.A., Cavanagh H.D. Expression of alpha-smooth muscle (alpha-SM) actin during corneal stromal wound healing. Invest. Ophthalmol. Vis. Sci. 1995, 36:809-819.
24. Jester J.V., Barry-Lane P.A., Petroll W.M., Olsen D.R., Cavanagh H.D. Inhibition of corneal fibrosis by topical application of blocking antibodies to TGF beta in the rabbit. Cornea 1997, 16:177-187.
25. Kyriakides T.R., Maclauchlan S. The role of thrombospondins in wound healing, ischemia, and the foreign body reaction. J. Cell Commun. Signal. 2009, 3:215-225.
26. Latvala T., Puolakkainen P., Vesaluoma M., Tervo T. Distribution of SPARC protein (osteonectin) in normal and wounded feline cornea. Exp. Eye Res. 1996, 63:579-584.
27. Lawler J. The functions of thrombospondin-1 and-2. Curr. Opin. Cell Biol. 2000, 12:634-640.
28. Leung L.L. Role of thrombospondin in platelet aggregation. J. Clin. Invest. 1984, 74:1764-1772.
29. Miyazaki K., Okada Y., Yamanaka O., Kitano A., Ikeda K., Kon S., Uede T., Rittling S.R., Denhardt D.T., Kao W.W., Saika S. Corneal wound healing in an osteopontin-deficient mouse. Invest. Ophthalmol. Vis. Sci. 2008, 49:1367-1375.
30. Moller-Pedersen T., Cavanagh H.D., Petroll W.M., Jester J.V. Neutralizing antibody to TGFbeta modulates stromal fibrosis but not regression of photoablative effect following PRK. Curr. Eye Res. 1998, 17:736-747.
31. Murphy-Ullrich J.E., Hook M. Thrombospondin modulates focal adhesions in endothelial cells. J. Cell Biol. 1989, 109:1309-1319.
32. Murphy-Ullrich J.E., Poczatek M. Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev. 2000, 11:59-69.
33. Murphy-Ullrich J.E., Schultz-Cherry S., Hook M. Transforming growth factor-beta complexes with thrombospondin. Mol. Biol. Cell 1992, 3:181-188.
34. Murphy-Ullrich J.E., Gurusiddappa S., Frazier W.A., Hook M. Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity. J. Biol. Chem. 1993, 268:26784-26789.
35. Roberts A.B. Molecular and cell biology of TGF-beta. Miner Electrolyte Metab. 1998, 24:111-119.
36. Roberts D.D. THBS1 (thrombospondin-1). Atlas Genet. Cytogenet. Oncol. Haematol. 2005.
37. Saika S., Yamanaka O., Okada Y., Tanaka S., Miyamoto T., Sumioka T., Kitano A., Shirai K., Ikeda K. TGF beta in fibroproliferative diseases in the eye. Front. Biosci. (Schol Ed.) 2009, 1:376-390.
38. Schlotzer-Schrehardt U., Zenkel M., Kuchle M., Sakai L.Y., Naumann G.O. Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome. Exp. Eye Res. 2001, 73:765-780.
39. Sekiyama E., Nakamura T., Cooper L.J., Kawasaki S., Hamuro J., Fullwood N.J., Kinoshita S. Unique distribution of thrombospondin-1 in human ocular surface epithelium. Invest. Ophthalmol. Vis. Sci. 2006, 47:1352-1358.
40. Sheibani N., Frazier W.A. Thrombospondin-1, PECAM-1, and regulation of angiogenesis. Histol. Histopathol 1999, 14:285-294.
41. Streit M., Velasco P., Riccardi L., Spencer L., Brown L.F., Janes L., Lange-Asschenfeldt B., Yano K., Hawighorst T., Iruela-Arispe L., Detmar M. Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice. EMBO J. 2000, 19:3272-3282.
42. Suda T., Nishida T., Ohashi Y., Nakagawa S., Manabe R. Fibronectin appears at the site of corneal stromal wound in rabbits. Curr. Eye Res. 1981, 1:553-556.
43. Tan K., Lawler J. The interaction of thrombospondins with extracellular matrix proteins. J. Cell Commun. Signal. 2009, 3:177-187.
44. Tandon A., Tovey J.C., Sharma A., Gupta R., Mohan R.R. Role of transforming growth factor Beta in corneal function, biology and pathology. Curr. Mol. Med. 2010, 10:565-578.
45. Taraboletti G., Roberts D.D., Liotta L.A. Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains. J. Cell Biol. 1987, 105:2409-2415.
46. Tervo K., van Setten G.B., Beuerman R.W., Virtanen I., Tarkkanen A., Tervo T. Expression of tenascin and cellular fibronectin in the rabbit cornea after anterior keratectomy. Immunohistochemical study of wound healing dynamics. Invest. Ophthalmol. Vis. Sci. 1991, 32:2912-2918.
47. Uno K., Hayashi H., Kuroki M., Uchida H., Yamauchi Y., Oshima K. Thrombospondin-1 accelerates wound healing of corneal epithelia. Biochem. Biophys. Res. Commun. 2004, 315:928-934.
48. van Setten G.B., Koch J.W., Tervo K., Lang G.K., Tervo T., Naumann G.O., Kolkmeier J., Virtanen I., Tarkkanen A. Expression of tenascin and fibronectin in the rabbit cornea after excimer laser surgery. Graefes Arch. Clin. Exp. Ophthalmol. 1992, 230:178-183.
49. Weimar V. The transformation of corneal stromal cells to fibroblasts in corneal wound healing. Am. J. Ophthalmol. 1957, 44:173-180. Discussion 180-172.
50. Wilson S.E., Mohan R.R., Ambrosio R., Hong J., Lee J. The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog. Retin. Eye Res. 2001, 20:625-637.
51. Xie X.S., Li F.Y., Liu H.C., Deng Y., Li Z., Fan J.M. LSKL, a peptide antagonist of thrombospondin-1, attenuates renal interstitial fibrosis in rats with unilateral ureteral obstruction. Arch. Pharm. Res. 2010, 33:275-284.
52. Zieske J.D., Gipson I.K. Protein synthesis during corneal epithelial wound healing. Invest. Ophthalmol. Vis. Sci. 1986, 27:1-7.
53. Zieske J.D., Higashijima S.C., Spurr-Michaud S.J., Gipson I.K. Biosynthetic responses of the rabbit cornea to a keratectomy wound. Invest. Ophthalmol. Vis. Sci. 1987, 28:1668-1677.
54. Zieske J.D., Guimaraes S.R., Hutcheon A.E. Kinetics of keratocyte proliferation in response to epithelial debridement. Exp. Eye Res. 2001, 72:33-39.
55. Zieske J.D., Hutcheon A.E., Guo X., Chung E.H., Joyce N.C. TGF-beta receptor types I and II are differentially expressed during corneal epithelial wound repair. Invest. Ophthalmol. Vis. Sci. 2001, 42:1465-1471.